Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $7.16 Million - $8.16 Million
24,139 Added 300.12%
32,182 $10.4 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $2.24 Million - $2.63 Million
8,043 New
8,043 $2.61 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Robeco Schweiz Ag Portfolio

Follow Robeco Schweiz Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Schweiz Ag, based on Form 13F filings with the SEC.

News

Stay updated on Robeco Schweiz Ag with notifications on news.